Concord Medical Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was TWD 443.11 million compared to TWD 357.66 million a year ago. Net income was TWD 26.84 million compared to TWD 12.06 million a year ago. Basic earnings per share from continuing operations was TWD 0.81 compared to TWD 0.48 a year ago. Diluted earnings per share from continuing operations was TWD 0.8 compared to TWD 0.48 a year ago.